Science ❯ Biotechnology ❯ Genetic Engineering

mRNA Technology

Vaccine Development Cancer Vaccines Therapeutics Therapeutic Applications Cancer Research Cancer Immunotherapy Cancer Treatment Personalized Medicine Clinical Trials Vaccine Mechanisms

5 ARTICLES

yesterday

Moderna and Merck Report Positive Phase 3 Results for Personalized mRNA Melanoma Vaccine

An interim analysis showed improved recurrence-free and distant-metastasis-free survival with no new safety signals, and the companies plan to release full data and begin regulatory discussions.

10 ARTICLES

2mo ago

Personalized mRNA Vaccine Halves Five‑Year Melanoma Recurrence Risk

5 ARTICLES

2mo ago

Individualized mRNA Vaccine Halves Five‑Year Melanoma Recurrence in Small Trial

4 ARTICLES

5mo ago

Australian Dog’s AI-Assisted mRNA Cancer Shot Shows Early Gains, Not Proof of a Cure

13 ARTICLES

5mo ago

Australian Tech Founder Uses ChatGPT and AlphaFold to Help Build Bespoke mRNA Cancer Vaccine for His Dog

3 ARTICLES

7mo ago

Bayer Files U.S. Patent Suits Against Pfizer, BioNTech, Moderna and J&J Over mRNA Tech

5 ARTICLES

10mo ago

mRNA COVID Vaccines Linked to Longer Survival With Cancer Immunotherapy, Nature Study Reports

4 ARTICLES

10mo ago

mRNA Allergy Vaccine Prevents Severe Reactions in Mice

3 ARTICLES

11mo ago

Intramuscular mRNA Vaccine Targets Wet AMD in Mice With Anti‑VEGF‑Like Efficacy

4 ARTICLES

last yr.

mRNA Neoantigen Vaccine Amplifies Anti-PD-1 Immunity and Suppresses Gastric Cancer Spread in Mice

6 ARTICLES

last yr.

GSK Secures $370 Million After CureVac US Patent Settlement

5 ARTICLES

last yr.

Trans-amplifying mRNA vaccine delivers broad SARS-CoV-2 variant protection with 40-fold lower dosage

10 ARTICLES

2y ago

Personalized mRNA Cancer Vaccines Show Promising Results in Trials

10 ARTICLES

2y ago

UK Begins Final Trials of Groundbreaking Personalized mRNA Cancer Vaccine

3 ARTICLES

2y ago

Moderna, Pfizer, BioNTech Clash in UK Court Over COVID-19 Vaccine Patents

mRNA Technology

Moderna and Merck Report Positive Phase 3 Results for Personalized mRNA Melanoma Vaccine

Personalized mRNA Vaccine Halves Five‑Year Melanoma Recurrence Risk

Individualized mRNA Vaccine Halves Five‑Year Melanoma Recurrence in Small Trial

Australian Dog’s AI-Assisted mRNA Cancer Shot Shows Early Gains, Not Proof of a Cure

Australian Tech Founder Uses ChatGPT and AlphaFold to Help Build Bespoke mRNA Cancer Vaccine for His Dog

Bayer Files U.S. Patent Suits Against Pfizer, BioNTech, Moderna and J&J Over mRNA Tech

mRNA COVID Vaccines Linked to Longer Survival With Cancer Immunotherapy, Nature Study Reports

mRNA Allergy Vaccine Prevents Severe Reactions in Mice

Intramuscular mRNA Vaccine Targets Wet AMD in Mice With Anti‑VEGF‑Like Efficacy

mRNA Neoantigen Vaccine Amplifies Anti-PD-1 Immunity and Suppresses Gastric Cancer Spread in Mice

GSK Secures $370 Million After CureVac US Patent Settlement

Trans-amplifying mRNA vaccine delivers broad SARS-CoV-2 variant protection with 40-fold lower dosage

Personalized mRNA Cancer Vaccines Show Promising Results in Trials

UK Begins Final Trials of Groundbreaking Personalized mRNA Cancer Vaccine

Moderna, Pfizer, BioNTech Clash in UK Court Over COVID-19 Vaccine Patents

Never miss stories about

mRNA Technology